Bank of Montreal’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bank of Montreal’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,000	Closed	-$355K	–	4932
2018 Q3	$355K	Hold	19,000	–	–	﹤0.01%	2479
2018 Q2	$491K	Buy	+19,000	New	+$493K	﹤0.01%	2343
2018 Q1	–	Sell	-500	Closed	-$13K	–	4422
2017 Q4	$13K	Buy	+500	New	+$12.2K	﹤0.01%	3710

Bank of Montreal's FLXN Position: Q4 2021 in Review

Bank of Montreal sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 171,879 shares — an estimated $1.1M sold.

Bank of Montreal first reported a position in FLXN in Q2 2014 and held it in 28 quarters. The position peaked at $2.21M in Q1 2017. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Bank of Montreal reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Bank of Montreal sold 171,879 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $1.1M.
Bank of Montreal first reported a position in Flexion Therapeutics, Inc. in Q2 2014 and held it in 28 quarters.
Bank of Montreal's Flexion Therapeutics, Inc. position peaked at $2.21M in Q1 2017.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.